Options Market Update January 25, 2016

After testing multi-year lows on Wednesday, the market was able to stabilize, rebound and close the week at its highs. For the week, the S&P 500 gained 1.41%, the Dow added 0.66% and the Nasdaq advanced 2.29%.

For the bulls, the action Wednesday was likely scary, but also exactly what they were looking for, as the Dow dropped over 550 points, in what may have been capitulation and the start of a relief rally. Also, Existing Home Sales, Consumer Confidence and Manufacturing PMI all beat expectations, and European Central Bank President Mario Draghi hinted that more stimulus may come as early as March.

For the bears, the issues that have concerned the market for so long, such as a slowing Chinese economy, commodity price destruction and fears of defaults in the oil sector, continued to weigh on the markets. These issues crushed the markets, as the Nasdaq lost over 15% in 14 trading days. Also, many top hedge fund managers are sounding warning bells about the possibility of a much larger selloff in the markets, and almost all stocks reporting earnings have so far been met with selling pressure.


The Chicago Board of Options Exchange Volatility Index (VIX) closed the week at 22.34, lower by 17%. This close in the low 20s came after the “fear index” spiked well above 30 at the lows of the selloff on Wednesday. Then, as the market stabilized and then ripped higher on Friday, the VIX and put premiums came in extremely hard.

While the VIX at 22 is still high, if the market stabilizes, I would anticipate put prices to get even cheaper, so if you feel you need portfolio protection, I wouldn’t talk you out of buying at these levels.

Events for the Week to Come

This week is packed with important economic releases, including Consumer Confidence, GDP and the Federal Reserve’s Announcement on Wednesday. Also, this will be the busiest week of earnings releases, including McDonald’s (MCD), Apple (AAPL), Boeing (BA), Facebook (FB) and Microsoft (MSFT). Unfortunately, until the U.S. market can get past “outside” events, I expect very little of this will matter if China’s market unwinds overnight or if oil makes another dramatic move.

What Traders are Saying

For the past two to three weeks, stocks like Kroger (KR) and Nvidia (NVDA) that had stood out amid the carnage have also failed. And the list of stocks above their 50- and 200-day moving averages have basically dwindled to a small handful of utility stocks—not the stocks that will produce the next home runs.

The next two weeks are packed with earnings releases, my favorite time to find new stocks to put on positions. In fact, I would almost prefer the market to stay somewhat weak during the next several weeks, as that makes it easier to find the next standout performers.

Earnings season has not yet yielded those new stars. Stocks that the bulls were hoping would lead, such as JPMorgan (JPM) Wells Fargo (WFC) and Intel (INTC), have so far disappointed. But there will undoubtedly be earnings stars, and we will likely target those stocks for new positions.

This is an excerpt from Cabot Options Trader, which features the most profitable investment strategies in any market. It’s your guide to quick profits using puts, calls, spreads, straddles, iron condors and other options trades. Analyst Jacob Mintz explains and recommends diverse investing strategies for big gains with controlled risk.

Subscriber reviews of Cabot Options Trader.

Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

How to Find Great Growth Stocks in a Scary Market

By Paul Goodwin on October 21, 2016

Even in today’s scary market, there are great growth stocks out there. Here’s how to find them—and how to avoid the kind of losses that can haunt your portfolio.Read More >

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >